News About: Pharm. Industry


Hospital's secret purchasing contract to be provisionally blocked.

The drug industry stressed that the hospital's secret contract in purchasing drugs with drug suppliers should be legally prohibited in order that the actual purchasing price system may be well settled down in future. ...

24.17% conventional margin for hospitals no longer permitted

By taking opportunity for imported drugs provisionally to eliminate any drug purchasing margins at hospitals, the KPMA concluded that 24.17% margins for hospitals would not be provided any longer, and decided to circu...

KRPIA rejected insurance price registration of imported drugs.

The KRPIA expressed a strong backlash against the government enforced launching schedule of insurance price registration for all imported drugs taking effect from July 1. The MOHW originally assumed to postpone the...

Major drug companies caught in trap of slow growth.

87 leading pharmaceutical firms made the total sales at 4,575,400 million won in 1998, which was merely 2.3% increase from the previous year of 4,474,100 million won and 7.2% point lower than 1997 of 9.6%, indicating ...

Multinational drug corporations made favorable growth.

It is very interested to see a contrast phenomena in business management performances between the local and the foreign multinational drug corporations after the IMF economic turmoil. The foreign multinational corpora...

Insurance reimbursement plan for imported drugs postponed to Sept.

The insurance reimbursement plan for imported drugs as originally scheduled to implement from July 1 may be set aside to coming September largely on account of premature time for preparation of its launching and a str...

Foreign joint venture companies took over shares of their local partners.

A traditional concept of foreign joint venture business partnership between a foreign pharmaceutical company and a local partner has been no longer perceived. After the IMF economic crisis the world top mu...

Insurance reimbursement price of imported drugs to review

The implementing schedule for the government insurance reimbursement and its pricing plan of imported drugs from upcoming July 1 has to be postponed largely in consideration with possible international trade frictions...

Minimum price system strongly to be requested by foreign Multinational drug makers.

In line with the government plan for medical insurance reimbursement approval on imported drugs the foreign multinational drug corporations put their total efforts firmly to keep compliance to so-called "Minimum Price...

Imported drug insurance plan requested one year postponement.

The Korea Pharmaceutical Trade Association (KPhTA) presented an official position paper to the MOHW titled "Proposal for insurance drug pricing of imported drugs" indicating that imported drugs under the current insur...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.